PriceTargets.com logo

Monogram Orthopaedics - MGRM Stock Price Target and Predictions

  • Consensus Rating: Strong Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 55.04%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 1 Strong Buy Ratings
$2.58 As of 12/20/2024 06:31 PM ET
▲ +0.07 (2.79%)

This chart shows the closing price for MGRM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Monogram Orthopaedics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MGRM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MGRM

Analyst Price Target is $4.00
▲ +55.04% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Monogram Orthopaedics in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 55.04% upside from the last price of $2.58.

This chart shows the closing price for MGRM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Strong Buy

The current consensus among 2 polled investment analysts is to buy (strong buy) stock in Monogram Orthopaedics.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/9/2024Roth CapitalUpgradeStrong-Buy
12/9/2024Roth MkmInitiated CoverageBuy$4.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 3 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 3 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Monogram Orthopaedics logo
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.
Read More

Today's Range

Now: $2.58
Low: $2.41
High: $2.62

50 Day Range

MA: $2.31
Low: $1.97
High: $2.85

52 Week Range

Now: $2.58
Low: $1.53
High: $4.90

Volume

129,635 shs

Average Volume

142,464 shs

Market Capitalization

$88.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2

Frequently Asked Questions

What sell-side analysts currently cover shares of Monogram Orthopaedics?

The following Wall Street research analysts have issued reports on Monogram Orthopaedics in the last twelve months: Roth Capital, and Roth Mkm.
View the latest analyst ratings for MGRM.

What is the current price target for Monogram Orthopaedics?

0 Wall Street analysts have set twelve-month price targets for Monogram Orthopaedics in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 55.0%. Roth Mkm has the highest price target set, predicting MGRM will reach $4.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $4.00 for Monogram Orthopaedics in the next year.
View the latest price targets for MGRM.

What is the current consensus analyst rating for Monogram Orthopaedics?

Monogram Orthopaedics currently has 1 buy rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Strong Buy."
View the latest ratings for MGRM.

What other companies compete with Monogram Orthopaedics?

Other companies that are similar to Monogram Orthopaedics include ZimVie, NeuroPace, AVITA Medical, CVRx and Sanara MedTech. Learn More about companies similar to Monogram Orthopaedics.

How do I contact Monogram Orthopaedics' investor relations team?

The company's listed phone number is 512-399-2656 and its investor relations email address is [email protected]. The official website for Monogram Orthopaedics is www.monogramorthopedics.com. Learn More about contacing Monogram Orthopaedics investor relations.